Repligen
RGEN
Rank 1223
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, US
Repligen - Key figures
Market cap 8.34 Billion
Revenue 734.1 Million
Profit 400.78 Million
P/E Ratio 59.47
P/s Ratio 11.36
Repligen - Description
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and internationally.
The company is headquartered in Waltham, Massachusetts.